Possible mechanisms of the beneficial action of glucocorticoids in circulatory shock.
D000818:Animals; D001794:Blood Pressure; D002415:Cats; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004285:Dogs; D005938:Glucocorticoids / Q000494:pharmacology / Q000627:therapeutic use*; D005966:Glucuronidase / Q000097:blood; D008638:Mesenteric Arteries / Q000187:drug effects; D008722:Methods; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology
D005938:Glucocorticoids; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D003907:Dexamethasone; D005966:Glucuronidase; D008775:Methylprednisolone